Monocyte recruitment and foam cell formation in atherosclerosis.
暂无分享,去创建一个
[1] J. Neefjes,et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. , 1992, Immunology.
[2] M. Takeichi,et al. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. , 1988, Development.
[3] Gerrity Rg. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .
[4] U. Steinbrecher,et al. Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. , 1991, The Journal of biological chemistry.
[5] K. Matsumoto,et al. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[6] A. Zernecke,et al. Involvement of JAM-A in Mononuclear Cell Recruitment on Inflamed or Atherosclerotic Endothelium: Inhibition by Soluble JAM-A , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[7] E. Fisher,et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Borén,et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis , 2002, Nature.
[9] O. Quehenberger,et al. Thematic Review Series: the Immune System and Atherogenesis Molecular Mechanisms Regulating Monocyte Recruitment in Atherosclerosis Thematic Review , 2005 .
[10] A. C. Nicholson,et al. CD36, oxidized LDL and PPARγ: pathological interactions in macrophages and atherosclerosis , 2004 .
[11] M. Takeichi,et al. Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.
[12] A. Zernecke,et al. Inflammatory mediators in atherosclerotic vascular disease , 2005, Basic Research in Cardiology.
[13] Qingbo Xu,et al. Atherosclerosis, autoimmunity, and vascular‐associated lymphoid tissue , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] Timothy A. Springer,et al. Adhesion receptors of the immune system , 1990, Nature.
[15] K. Moore,et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.
[16] Y. Bobryshev,et al. Formation of Birbeck granule-like structures in vascular dendritic cells in human atherosclerotic aorta. Lag-antibody to epidermal Langerhans cells recognizes cells in the aortic wall. , 1997, Atherosclerosis.
[17] A. Zernecke,et al. JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes , 2002, Nature Immunology.
[18] M. Davies,et al. The expression of the adhesion molecules ICAM‐1, VCAM‐1, PECAM, and E‐selectin in human atherosclerosis , 1993, The Journal of pathology.
[19] R. Stocker,et al. Lipid oxidation in atherogenesis: an overview. , 2004, Biochemical Society transactions.
[20] L. Stanton,et al. CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.
[21] Y. Bobryshev,et al. Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta. Hypothetical role of ganglioside GM3 in foam cell formation. , 2001, Biochimica et biophysica acta.
[22] Y. Bobryshev,et al. The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions. , 1998, Cardiovascular research.
[23] Andrew C. Li,et al. The macrophage foam cell as a target for therapeutic intervention , 2002, Nature Medicine.
[24] D. Greaves,et al. Atherosclerosis: role of chemokines and macrophages , 2001, Expert Reviews in Molecular Medicine.
[25] J. Skepper,et al. Macrophage death and the role of apoptosis in human atherosclerosis. , 2001, Journal of hematotherapy & stem cell research.
[26] N. Maeda,et al. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. , 1999, Atherosclerosis.
[27] M. Ala-Korpela,et al. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. , 2000, Journal of lipid research.
[28] M. Parkes,et al. Ulcerative colitis and Crohn's disease: molecular genetics and clinical implications , 2001, Expert Reviews in Molecular Medicine.
[29] Y. Bobryshev,et al. Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation. , 1999, Cardiovascular research.
[30] K. Pettigrew,et al. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. , 1998, Stroke.
[31] V. Mehra,et al. Cytokines and cardiovascular disease , 2005, Journal of leukocyte biology.
[32] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[33] Richard G. W. Anderson,et al. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins , 1979, The Journal of cell biology.
[34] M. Cybulsky,et al. Leukocyte recruitment to atherosclerotic lesions. , 2004, The Canadian journal of cardiology.
[35] M. Linton,et al. Conditional Knockout of Macrophage PPARγ Increases Atherosclerosis in C57BL/6 and Low-Density Lipoprotein Receptor–Deficient Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[36] J. Boyle,et al. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. , 2005, Current vascular pharmacology.
[37] K. Williams,et al. Lipoprotein retention--and clues for atheroma regression. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[38] M. Ilyas,et al. THE INTERACTIONS OF APC, E‐CADHERIN AND β‐CATENIN IN TUMOUR DEVELOPMENT AND PROGRESSION , 1997, The Journal of pathology.
[39] I. Charo,et al. Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.
[40] Qingbo Xu,et al. Autoimmune and inflammatory mechanisms in atherosclerosis. , 2004, Annual review of immunology.
[41] François Mach,et al. Inflammation and Atherosclerosis , 2004, Herz.
[42] V. Babaev,et al. Monocyte/macrophage accumulation and smooth muscle cell phenotypes in early atherosclerotic lesions of human aorta. , 1993, Atherosclerosis.
[43] J. Loscalzo,et al. Cellular adhesion molecules and atherogenesis. , 1999, The American journal of medicine.
[44] M. Linton,et al. ACAT inhibition: bad for macrophages, good for smooth muscle cells? , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[45] P. Libby,et al. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.
[46] J. Plutzky,et al. Atherosclerotic plaque rupture: emerging insights and opportunities. , 1999, The American journal of cardiology.
[47] S. Blankenberg,et al. Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.
[48] M. Ala-Korpela,et al. Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. , 2000, Biochimica et biophysica acta.
[49] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[50] D. Steinberg,et al. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. , 1989, The Journal of biological chemistry.
[51] D. Altshuler,et al. The role of PPAR-γ in macrophage differentiation and cholesterol uptake , 2001, Nature Medicine.
[52] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[53] E. Smart,et al. Macrophage scavenger receptors and foam cell formation , 1999, Journal of leukocyte biology.
[54] Roger A. Davis,et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ , 2004 .
[55] W D Wagner,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[56] R. Steinman,et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. , 1998, Science.
[57] P. Libby,et al. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. , 1993, The Journal of clinical investigation.
[58] G. Byrne,et al. A Chlamydia pneumoniae Component That Induces Macrophage Foam Cell Formation Is Chlamydial Lipopolysaccharide , 1998, Infection and Immunity.
[59] S. Wesselborg,et al. Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses. , 2003, Critical reviews in immunology.
[60] C. Alpers,et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.
[61] K. Matsumoto,et al. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. , 1999, Circulation research.
[62] M. Takeya,et al. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals , 2002, Medical Electron Microscopy.
[63] G. Hansson. Immune mechanisms in atherosclerosis. , 1989, Arteriosclerosis, thrombosis, and vascular biology.
[64] S. Hazen,et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.
[65] T. Kodama,et al. Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. , 1999, Atherosclerosis.
[66] B. Staels,et al. The role of PPARs in atherosclerosis. , 2002, Trends in molecular medicine.
[67] S. Gordon,et al. Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence. , 1998, Current opinion in lipidology.
[68] Y. Bobryshev,et al. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta. , 1995, Archives of histology and cytology.
[69] T. Kodama,et al. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[70] G. Byrne,et al. Induction of macrophage foam cell formation by Chlamydia pneumoniae. , 1998, The Journal of infectious diseases.
[71] Z. Lijun,et al. Role of macrophage and smooth muscle cell apoptosis in association with oxidized low-density lipoprotein in the atherosclerotic development , 2005, Modern Pathology.
[72] V. Fuster,et al. Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.
[73] T. Carew,et al. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. , 1989, Arteriosclerosis.
[74] J. Ge,et al. Ciglitazone Inhibits Oxidized-Low Density Lipoprotein Induced Immune Maturation of Dendritic Cells , 2004, Journal of cardiovascular pharmacology.
[75] P. Yancey,et al. Crystallization of free cholesterol in model macrophage foam cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[76] P. Yancey,et al. The Role of Microscopy in Understanding Atherosclerotic Lysosomal Lipid Metabolism , 2003, Microscopy and Microanalysis.
[77] J L Witztum,et al. Lipoproteins and atherogenesis. Current concepts. , 1990, JAMA.
[78] Robert V Farese,et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.
[79] E. Chavakis,et al. The role of junctional adhesion molecule‐C (JAM‐C) in oxidized LDL‐mediated leukocyte recruitment , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[80] H. Kruth. Sequestration of aggregated low-density lipoproteins by macrophages , 2002, Current opinion in lipidology.
[81] A. Daugherty,et al. Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.R500009-JLR200 , 2005, Journal of Lipid Research.
[82] R. Gerrity,et al. The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. , 1981, The American journal of pathology.
[83] Jody C. Ullery,et al. Aggregated LDL and lipid dispersions induce lysosomal cholesteryl ester accumulation in macrophage foam cells Published, JLR Papers in Press, July 16, 2005. DOI 10.1194/jlr.M500059-JLR200 , 2005, Journal of Lipid Research.
[84] A. Varki,et al. Selectin ligands. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[85] E. Ikonen,et al. Macrophage cholesterol transport: a critical player in foam cell formation , 2003, Annals of medicine.
[86] Yukiko Kurihara,et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.
[87] B. Ludewig,et al. The in and out of monocytes in atherosclerotic plaques: Balancing inflammation through migration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[88] A. G. Vinogradov,et al. Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. , 1985, Atherosclerosis.
[89] M. Brown,et al. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.
[90] C. Funk,et al. The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. , 2005, Biochimica et biophysica acta.
[91] H. Kruth,et al. Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2002, The Journal of Biological Chemistry.
[92] I. Tabas,et al. Cholesterol and phospholipid metabolism in macrophages. , 2000, Biochimica et biophysica acta.
[93] K. Moore,et al. Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages* , 2002, The Journal of Biological Chemistry.
[94] Y. Bobryshev. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. , 2005, European heart journal.
[95] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[96] W. Rabl,et al. A Previously Unrecognized Site of Local Accumulation of Mononuclear Cells , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[97] R. Poston,et al. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. , 1994, The American journal of pathology.
[98] V. Ord,et al. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. , 1992, The American journal of pathology.
[99] H. Itabe. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. , 2003, Biological & pharmaceutical bulletin.
[100] Peter Libby,et al. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.
[101] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[102] D. Malide,et al. Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2005, Journal of Biological Chemistry.
[103] G. Hansson,et al. Chemokines and atherosclerosis , 2004, Annals of medicine.
[104] M. Linton,et al. Macrophages, inflammation, and atherosclerosis , 2003, International Journal of Obesity.
[105] A. C. Nicholson. Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling. , 2004, Trends in cardiovascular medicine.
[106] Siamon Gordon,et al. Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400011-JLR200 , 2005, Journal of Lipid Research.
[107] S. Yamashita,et al. Localization of CD36 and scavenger receptor class A in human coronary arteries--a possible difference in the contribution of both receptors to plaque formation. , 2001, Atherosclerosis.
[108] S. Hirohashi,et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. , 1989, Cancer research.
[109] K. Ley,et al. Macrophage differentiation to foam cells. , 2005, Current pharmaceutical design.
[110] T. Carew,et al. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. , 1989, Arteriosclerosis.
[111] M. Freeman. Scavenger receptors in atherosclerosis , 1997, Current opinion in hematology.
[112] P. Kovanen,et al. Proteolysis of the Pericellular Matrix: A Novel Element Determining Cell Survival and Death in the Pathogenesis of Plaque Erosion and Rupture , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[113] Y. Bobryshev,et al. Subset of vascular dendritic cells transforming into foam cells in human atherosclerotic lesions. , 1997, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[114] T. Cohnert,et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[115] T. Kodama,et al. Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[116] M. Linton,et al. Class A scavenger receptors, macrophages, and atherosclerosis , 2001, Current opinion in lipidology.
[117] M. Linton,et al. ACAT1 Deficiency Disrupts Cholesterol Efflux and Alters Cellular Morphology in Macrophages , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[118] B. Chain,et al. Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? , 2002, Cardiovascular research.
[119] Klaus Ley,et al. L-Selectin Shedding Regulates Leukocyte Recruitment , 2001, The Journal of experimental medicine.
[120] V. Fuster,et al. Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis , 2004, Journal of Thrombosis and Thrombolysis.
[121] Y. Bobryshev. Intracellular Localization of Oxidized Low-density Lipoproteins in Atherosclerotic Plaque Cells Revealed by Electron Microscopy Combined with Laser Capture Microdissection , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[122] R. Natarajan,et al. Monocyte retention in the pathology of atherosclerosis. , 2005, Future cardiology.
[123] S. Heidenreich. Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides , 1999, Journal of leukocyte biology.
[124] H. Hammad,et al. Peroxisome Proliferator-Activated Receptor γ Inhibits the Migration of Dendritic Cells: Consequences for the Immune Response1 , 2003, The Journal of Immunology.
[125] W. Brugger,et al. Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor γ1 , 2002, The Journal of Immunology.
[126] K. Gaus,et al. Oxidized lipoproteins and macrophages. , 2002, Vascular pharmacology.
[127] Y. Bobryshev,et al. Dendritic cells and their involvement in atherosclerosis , 2000, Current opinion in lipidology.
[128] M. Ferguson,et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. , 1993, The Journal of clinical investigation.
[129] G. Byrne,et al. Chlamydia pneumoniae and atherosclerosis: links to the disease process. , 1999, American heart journal.
[130] Y. Bobryshev,et al. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. , 1998, Cardiovascular research.
[131] H. Niederegger,et al. Network of Vascular-Associated Dendritic Cells in Intima of Healthy Young Individuals , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[132] H. Aburatani,et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[133] I. Tabas. Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[134] D. Rader,et al. Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? , 2005, Cell metabolism.
[135] N. E. Rossett,et al. Peptic ulcer: medical cure by efficient gastric acid neutralization. , 1952, Annals of internal medicine.